The stock of Conmed Corp. (NYSE:CNMD) last traded at $80.08, down -0.07% from the previous session.
CNMD stock price is now -5.84% away from the 50-day moving average and -23.68% away from the 200-day moving average. The market capitalization of the company currently stands at $2.46B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $119 to $129, Needham maintained Buy rating for Conmed Corp. (NYSE: CNMD). On May 22, 2023, CL King recently initiated its ‘Buy’ rating on the stock quoting a target price of $140, while ‘KeyBanc Capital Markets’ rates the stock as ‘Overweight’
In other news, Peters Stanley W III, President AS and AET sold 2,300 shares of the company’s stock on Dec 04 ’23. The stock was sold for $252,833 at an average price of $109.93. Upon completion of the transaction, the President AS and AET now directly owns 63 shares in the company, valued at $5045.04. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 07 ’23, President AS and AET Peters Stanley W III sold 1,200 shares of the business’s stock. A total of $122,874 was realized by selling the stock at an average price of $102.39. This leaves the insider owning 63 shares of the company worth $5045.04. A total of 0.79% of the company’s stock is owned by insiders.
During the past 12 months, Conmed Corp. has had a low of $74.67 and a high of $138.47. As of last week, the company has a debt-to-equity ratio of 1.19, a current ratio of 1.98, and a quick ratio of 0.96. According to the stock market information, the enterprise value for the company is $3.42B, which is based on a 39.26 price-to-earnings ratio, a 1.55 price-to-earnings-growth ratio, and a beta of 1.33. The fifty day moving average price for CNMD is $85.05 and a two-hundred day moving average price translates $104.93 for the stock.
The latest earnings results from Conmed Corp. (NYSE: CNMD) was released for Dec, 2023. According to the Medical Devices Company, earnings per share came in at $1.06, missing analysts’ expectations of $1.11 by -0.05. This compares to $1.06 EPS in the same period last year. The net profit margin was 5.19% and return on equity was 8.16% for CNMD. The company reported revenue of $327.05 million for the quarter, compared to $250.87 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 30.37 percent. For the current quarter, analysts expect CNMD to generate $306.78M in revenue.
